Cell-Type Specific Single-Cell Signatures Reveal Nephrotoxic Drug Affects

Area of Science:

• Nephrology
• Genomics
• Toxicology

Background:

• Drug-induced acute kidney injury (AKI) is a significant cause of morbidity and mortality in hospitalized patients.
• Current biomarkers for AKI, such as creatinine levels, are only effective after substantial kidney damage has occurred.
• Understanding the cellular mechanisms of drug-induced AKI is limited, hindering effective prediction and prevention.

Purpose of the Study:

• To investigate the hypothesis that specific kidney cell subtypes are responsible for nephrotoxicity.
• To identify cellular targets for predicting and mitigating drug-induced AKI.
• To explore the utility of single-cell RNA sequencing (scRNAseq) in understanding AKI mechanisms.

Main Methods:

• Utilized single-cell RNA sequencing (scRNAseq) data from the Human Cell Atlas.
• Generated cellular response scores for 32 distinct kidney cell types.
• Developed an ensemble model integrating scRNAseq data to predict drug effects.

Main Results:

• Identified significant gene expression differences in 6 specific kidney cell types, including Indistinct intercalated cells and Epithelial Progenitor cells.
• The developed ensemble model achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.6.
• This performance represents a significant improvement over traditional bulk RNA sequencing methods for predicting AKI.

Conclusions:

• Single-cell transcriptomic signatures can elucidate previously unexplained molecular mechanisms of nephrotoxicity.
• scRNAseq offers a powerful tool for dissecting cellular heterogeneity in AKI.
• Identifying susceptible cell subtypes may lead to improved prediction and targeted therapies for drug-induced AKI.